| Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells M Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ... Blood, The Journal of the American Society of Hematology 137 (5), 624-636, 2021 | 188 | 2021 |
| Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells H Shaim, M Shanley, R Basar, M Daher, J Gumin, DB Zamler, N Uprety, ... The Journal of Clinical Investigation 131 (14), 2021 | 155 | 2021 |
| Leptomeningeal Metastasis from Non–Small Cell Lung Cancer and Current Landscape of Treatments G Ozcan, M Singh, JJ Vredenburgh Clinical Cancer Research 29 (1), 11-29, 2023 | 40 | 2023 |
| Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells R Basar, M Daher, N Uprety, E Gokdemir, A Alsuliman, E Ensley, G Ozcan, ... Blood advances 4 (14), 3357-3367, 2020 | 30 | 2020 |
| A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation L Li, H Chen, D Marin, Y Xi, Q Miao, J Lv, PP Banerjee, H Shaim, M Daher, ... Blood Advances 3 (23), 4117-4130, 2019 | 29 | 2019 |
| Doege-Potter syndrome with a benign solitary fibrous tumor: a case report and literature review T Mohammed, G Ozcan, AS Siddique, RN Araneta III, DE Slater, A Khan Case Reports in Oncology 14 (1), 470-476, 2021 | 21 | 2021 |
| Primary Hepatic Extra-gastrointestinal Stromal Tumors: Molecular Pathogenesis, Immunohistopathology, and Treatment EC Becker, G Ozcan, GY Wu Journal of Clinical and Translational Hepatology 11 (4), 942, 2023 | 2 | 2023 |
| Impact of a shared-care model between community and academic centers for facilitating access to allogeneic and autologous stem cell transplantation. JA Fein, A McAuliffe, K Fischer, O Brady, SM Devlin, S Willumsen, ... Journal of Clinical Oncology 40 (16_suppl), 1510-1510, 2022 | 2 | 2022 |
| CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor M Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ... bioRxiv, 2020.03. 29.014472, 2020 | 2 | 2020 |
| Combining CAR Engineering and CIS Checkpoint Deletion in NK Cells for the Treatment of B Cell Hematologic Malignancies M Daher, R Basar, E Gokdemir, N Baran, N Uprety, MC Mendt, L Kerbauy, ... Blood 134, 1936, 2019 | 2 | 2019 |
| Not a Statin-Induced Myopathy: Metastatic Pancreatic Adenocarcinoma Presenting As Paraneoplastic Myositis G Ozcan, A Shaikh, E Becker, N Perosevic Cureus 14 (5), 2022 | 1 | 2022 |
| Subject adherence: are the subjects following the protocol? If not, how to assess and analyze (intention to treat vs. per protocol) G Ozcan, M Singh, EM Mortensen Translational Radiation Oncology, 437-443, 2023 | | 2023 |
| Surveys and questionnaires: design, measures, and classical examples G Ozcan, M Singh, EM Mortensen Translational Radiation Oncology, 283-290, 2023 | | 2023 |
| Transplant Outcomes for TP53 AML and MDS in a Contemporary Era G Ozcan, UR Popat, P Kebriaei, AM Alousi, G Alatrash, Q Bashir, ... Blood 140 (Supplement 1), 10620-10621, 2022 | | 2022 |
| Home-based geriatric oncology care: A feasibility study. G Ozcan, J Braish, TJ Mohammed, C Hong, N Mott, M Eanniello, ... Journal of Clinical Oncology 40 (28_suppl), 62-62, 2022 | | 2022 |
| Peritoneal Carcinomatosis as an Initial Presentation of Gastrointestinal Stromal Tumor: A Case Report and Review of the Literature G Ozcan, G Gautam, T Da Cunha, EC Becker, N Perosevic Cureus 14 (6), 2022 | | 2022 |
| Comparison of Mitoxantrone versus Cyclophosphamide Treatment in Patients with Secondary Progressive Multiple Sclerosis T Gündüz, G Özcan, A Çakar, Hİ Akçay, ANÖ Acarlı, M Eraksoy, ... Dicle Tıp Dergisi 49 (1), 29-35, 2022 | | 2022 |
| An evaluation of patient workflow in hematology clinics at a university hospital referred for the workup of monoclonal gammopathy of undetermined significance (MGUS). S Kumar, RB Kulkarni, G Ozcan, A Tipirneni, R Vankina, WJ Baker Journal of Clinical Oncology 39 (28_suppl), 207-207, 2021 | | 2021 |
| NOT A STATIN-INDUCED MYOPATHY: PANCREATIC ADENOCARCINOMA PRESENTED AS PARANEOPLASTIC MYOSITIS G Ozcan, N Perosevic JOURNAL OF GENERAL INTERNAL MEDICINE 36 (SUPPL 1), S184-S185, 2021 | | 2021 |
| When the Liver Goes Bad, Life Goes Sad-Severe Resistant Hepatic Encephalopathy Due to Fibrolamellar Hepatic Cancer G Ozcan, M Hadfield, N Perosevic TP142. TP142 THORACIC ONCOLOGY: RARE LUNG TUMORS/METASTATIC DISEASE, A4935-A4935, 2021 | | 2021 |
